Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PRINSTON INC

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 48
  • 0 comments

FDA approve VALSARTAN

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 41
  • 0 comments

FDA approve ALBUMIN HUMAN

Comment Full text

AM REGENT

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 52
  • 0 comments

FDA approve CAFFEINE CITRATE

Comment Full text

TEVA

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 47
  • 0 comments

FDA approve CEPHALEXIN

Comment Full text

TEVA

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 48
  • 0 comments

FDA approve CEPHALEXIN

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 52
  • 0 comments

FDA approve MIRTAZAPINE

Comment Full text

HOSPIRA

  • FDA Approval
  • May 14, 2025, 08:43 UTC
  • 55
  • 0 comments

FDA approve DEFEROXAMINE MESYLATE

Comment Full text

CHEMI SPA

  • FDA Approval
  • May 09, 2025, 08:45 UTC
  • 52
  • 0 comments

FDA approve GLATIRAMER ACETATE

Comment Full text

CUBIST PHARMS LLC

  • FDA Approval
  • May 09, 2025, 08:45 UTC
  • 55
  • 0 comments

FDA approve DAPTOMYCIN

Comment Full text

RUBICON

  • FDA Approval
  • May 09, 2025, 08:45 UTC
  • 51
  • 0 comments

FDA approve LABETALOL HYDROCHLORIDE

Comment Full text
  • Previous
  • 141
  • 142
  • 143
  • 144
  • 145
  • Next

Search

News categories

  • Technical Exchange News(10590)
  • Event(2007)
  • SEC News(184691)
  • FDA Approval(9842)
  • Company Report(721)
  • Business News(122330)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin